Healthtech funding in Q2 2023
European Healthtech startup funding raised during Q2 2023.
In Q2 2023, 130 European Healthtech companies closed 132 funding rounds and raised €1.3B in equity funding (excluding debt and grants), down 33.0% versus Q2 2022. Debt rounds added €34M. France led by capital raised, and High-Tech Gründerfonds (HTGF) was the most active investor. Data as of 20 Nov 2026.
Equity funding
€1.3B
-33.0% vs Q2 2022 · excl. debt & grants · +€34M debt
Funding rounds
132
-16.5% vs Q2 2022
Companies
130
Top country
France
Rank among sectors
#5
9.3% of sector funding
Debt financing
€34M
2.5% of total
Top-10 round share
56.4%
of disclosed capital
Rounds ≥ €100M
3
Funding by month
€ raised vs rounds, by monthHealthtech — funding by month, Q2 2023 — interactive chart.
Data table
| Funding | Rounds | |
|---|---|---|
| Apr | €443M | 45 |
| May | €585M | 47 |
| Jun | €309M | 40 |
Top countries
by € raisedHealthtech — top countries by capital, Q2 2023 — interactive chart.
Data table
| Healthtech — top countries by capital, Q2 2023 | |
|---|---|
| France | €277M |
| Germany | €268M |
| UK | €248M |
| Switzerland | €205M |
| Sweden | €86M |
| Spain | €73M |
| Netherlands | €72M |
| Ireland | €35M |
Stage mix
by € raisedHealthtech — stage mix, Q2 2023 — interactive chart.
Data table
| Healthtech — stage mix, Q2 2023 | |
|---|---|
| Other | €582M |
| Series A | €277M |
| Series C | €186M |
| Series B | €102M |
| Seed | €82M |
| Series D+ | €50M |
| Debt | €34M |
| Pre-Seed | €9.9M |
| Grant | €9.9M |
| Crowdfunding | €3.1M |
| Early VC | €2.5M |
Top deals
largest disclosed rounds in Q2 2023| Company | Stage | Date | Amount |
|---|---|---|---|
| DistalMotion | Other | Apr 2023 | €137M |
| Ascend | Other | May 2023 | €121M |
| Patient21 | Series C | May 2023 | €100M |
| Humble | Other | Jun 2023 | €74M |
| Complement Therapeutics | Series A | Apr 2023 | €72M |
| Corwave | Series C | Jun 2023 | €61M |
| Moon Surgical | Other | May 2023 | €51M |
| Tissium | Series D+ | May 2023 | €50M |
| NewBiologix | Series A | May 2023 | €46M |
| Arthex Biotech | Series B | May 2023 | €42M |
| VarmX | Series B | May 2023 | €30M |
| Woodoo | Other | Apr 2023 | €28M |
| NVision Imaging | Series A | Jun 2023 | €28M |
| DiogenX | Series A | May 2023 | €28M |
| Gleamer | Series B | Jun 2023 | €27M |
Top investors
most active in Q2 2023, by deal count- High-Tech Gründerfonds (HTGF)6 deals
- European Innovation Council (EIC)5 deals
- Innovate UK5 deals
- Octopus Ventures4 deals
- AdBio partners3 deals
- Clave Capital3 deals
- MassMutual Ventures (MMV)3 deals
- Sofinnova Partners3 deals
- Atlantic Labs2 deals
- Bpifrance2 deals